Posts

NANO2021 NFR Program: Norwegian Research Council Funds AlgiPharma Consortium 9.750.000 NOK for advanced wound healing applications

AlgiPharma is part of a multi-disciplinary consortium that has been awarded funding from the Research Council of Norway (NANO2021 programme). The Research project called NanoHeal, led by the Paper and Fibre Research Institute (PFI), includes a range of international partners (NTNU, Faculty of medicine, Cardiff University, Swansea University and Lund University) investigating bio-compatible cellulose nanostructures for advanced wound healing applications.

For further information, please contact:
Philip D. Rye R&D Director; phil.rye@algipharma.com

October 2012

US Department of Defense supports an AlgiPharma initiated in vivo wound healing study on OligoG

AlgiPharma has together with Prof. Chandan Sen, at Ohio State University embarked on a study to investigate the effects of OligoG in a unique biofilm infected in vivo wound healing model.

For further information, please contact:
Philip D. Rye R&D Director; phil.rye@algipharma.com

August 2010